Healthequity (HQY) Stock Price

Healthequity Price

NASDAQ·CLOSED
100.61USD-0.38 (-0.38 %)
Market closed

Revenue has compounded at 29.4% per year over the past 13 years to 1.31 B USD. Earnings per share have grown at 18.9% per year over the last 13 years. Healthequity's net margin stands at 16.4%, up from -5.9% several years earlier. Analysts set a median price target of 125.97 USD, implying 25.2% above the current price. Of 20 analysts, 17 rate the stock a buy — an overall Buy consensus. The stock trades about 37% above its 52-week low.

Healthequity stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Healthequity over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Healthequity stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Healthequity's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Healthequity Stock Price History
DateHealthequity Price
7/31/2026100.61 USD
7/30/2026100.99 USD
7/29/2026103.39 USD
7/27/202698.28 USD
7/23/202694.33 USD
7/22/202695.95 USD
7/21/202697.77 USD
7/20/202698.88 USD
7/17/202697.67 USD
7/16/202698.69 USD
7/15/202695.07 USD
7/14/202694.50 USD
7/13/202695.29 USD
7/10/202694.40 USD
7/9/202694.81 USD
7/8/202695.40 USD
7/7/202696.98 USD
7/6/202696.84 USD
7/2/202695.31 USD
7/1/202692.29 USD
6/30/202690.32 USD
6/29/202686.50 USD
6/26/202688.46 USD
6/25/202683.43 USD
6/24/202685.00 USD
6/23/202684.92 USD
6/22/202684.64 USD
6/18/202684.99 USD
6/17/202685.60 USD
6/16/202685.87 USD
6/15/202686.58 USD
6/12/202687.42 USD
6/11/202688.26 USD
6/10/202689.78 USD
6/9/202689.23 USD
6/8/202687.84 USD
6/5/202687.67 USD
6/4/202688.10 USD
6/3/202685.32 USD
6/2/202688.21 USD
6/1/202690.81 USD
5/29/202689.16 USD
5/28/202689.56 USD
5/27/202688.08 USD
5/26/202687.38 USD
5/22/202686.93 USD
5/21/202686.01 USD
5/20/202685.86 USD
5/19/202684.65 USD
5/18/202683.04 USD
5/15/202682.17 USD
5/14/202682.32 USD
5/13/202682.18 USD
5/12/202680.46 USD
5/11/202681.65 USD
5/8/202684.84 USD
5/7/202683.99 USD
5/6/202683.25 USD
5/5/202682.63 USD
5/4/202682.18 USD
5/1/202682.40 USD
4/30/202682.03 USD
4/29/202681.48 USD
4/28/202681.18 USD
4/27/202683.52 USD
4/24/202682.45 USD
4/23/202677.75 USD
4/22/202682.88 USD
4/21/202684.30 USD
4/20/202686.33 USD
4/17/202686.04 USD
4/16/202684.53 USD
4/15/202683.67 USD
4/14/202681.36 USD
4/13/202679.91 USD
4/10/202677.96 USD
4/9/202684.20 USD
4/8/202681.95 USD
4/7/202681.08 USD
4/6/202683.44 USD
4/5/202683.44 USD
4/2/202684.67 USD
4/1/202684.67 USD
3/31/202683.38 USD
3/30/202683.57 USD
3/29/202681.48 USD
3/27/202682.51 USD
3/26/202682.51 USD
3/25/202683.85 USD
3/24/202682.47 USD
3/23/202682.10 USD
3/22/202681.64 USD
3/20/202681.02 USD
3/19/202681.02 USD
3/18/202681.13 USD
3/17/202679.57 USD
3/16/202679.40 USD
3/15/202678.67 USD
3/13/202677.81 USD
3/12/202677.81 USD
3/11/202676.79 USD
3/10/202678.57 USD
3/9/202678.50 USD
3/8/202680.04 USD
3/6/202678.36 USD
3/5/202679.96 USD
3/4/202681.15 USD
3/3/202680.43 USD
3/2/202677.93 USD
2/27/202676.49 USD
2/26/202677.39 USD
2/25/202675.56 USD
2/24/202675.89 USD
2/23/202675.87 USD
2/20/202678.90 USD
2/19/202678.88 USD
2/18/202677.11 USD
2/17/202674.36 USD
2/13/202673.88 USD
2/12/202673.88 USD
2/11/202673.21 USD
2/10/202676.92 USD
2/9/202678.35 USD
2/8/202679.28 USD
2/6/202679.45 USD
2/5/202679.45 USD
2/4/202679.22 USD
2/3/202681.34 USD
2/2/202682.12 USD
2/1/202687.07 USD
1/30/202685.67 USD
1/29/202685.67 USD
1/28/202683.57 USD
1/27/202682.85 USD
1/26/202683.02 USD
1/25/202685.33 USD
1/23/202684.11 USD
1/22/202684.11 USD
1/21/202686.42 USD
1/20/202684.59 USD
1/19/202684.00 USD
1/16/202685.37 USD
1/15/202685.37 USD
1/14/202686.94 USD
1/13/202685.60 USD
1/12/202684.28 USD
1/11/202684.56 USD
1/9/202694.15 USD
1/8/202694.15 USD
1/7/202698.51 USD
1/6/202697.77 USD
1/5/202695.45 USD
1/4/202693.47 USD
1/2/202691.07 USD
1/1/202691.07 USD
12/31/202591.61 USD
12/30/202591.61 USD
12/29/202592.50 USD
12/28/202592.78 USD
12/26/202593.48 USD
12/25/202593.48 USD
12/24/202592.45 USD
12/23/202592.45 USD
12/22/202592.69 USD
12/21/202593.78 USD
12/19/202595.50 USD
12/18/202595.50 USD
12/17/202595.50 USD
12/16/202595.31 USD
12/15/202596.00 USD
12/14/202595.75 USD
12/12/202596.79 USD
12/11/202596.79 USD
12/10/202597.39 USD
12/9/202595.73 USD
12/8/202593.26 USD
12/7/202592.09 USD
12/5/202594.51 USD
12/4/202594.51 USD
12/3/202595.67 USD
12/2/202598.64 USD
12/1/202598.88 USD
11/30/2025102.41 USD
11/28/2025105.18 USD
11/27/2025105.18 USD
11/26/2025104.99 USD
11/25/2025104.99 USD
11/24/2025105.44 USD
11/23/2025103.64 USD
11/21/2025101.91 USD
11/20/2025101.91 USD
11/19/2025100.73 USD
11/18/2025103.55 USD
11/17/2025102.74 USD
11/16/2025100.17 USD
11/14/2025101.77 USD
11/13/2025101.77 USD
11/12/202599.50 USD
11/11/2025100.50 USD
11/10/202599.83 USD
11/9/202599.83 USD
11/7/202593.71 USD
11/6/202593.71 USD
11/5/202592.74 USD
11/4/202594.39 USD
11/3/202595.04 USD
11/2/202594.81 USD
10/31/202594.58 USD
10/30/202594.58 USD
10/29/202592.95 USD
10/28/202594.44 USD
10/27/202595.15 USD
10/26/202596.17 USD
10/23/202596.50 USD
10/22/202596.34 USD
10/21/202595.48 USD
10/20/202596.00 USD
10/19/202593.03 USD
10/16/202591.46 USD
10/15/202591.04 USD
10/14/202592.55 USD
10/13/202594.04 USD
10/12/202593.23 USD
10/9/202590.52 USD
10/8/202592.78 USD
10/7/202592.09 USD
10/6/202588.50 USD
10/5/202587.78 USD
10/2/202588.59 USD
10/1/202589.68 USD
9/30/202590.71 USD
9/29/202594.77 USD
9/28/202595.34 USD
9/25/202596.53 USD
9/24/202596.16 USD
9/23/202594.26 USD
9/22/202593.85 USD
9/21/202595.97 USD
9/18/202593.74 USD
9/17/202595.59 USD
9/16/202592.28 USD
9/15/202591.54 USD
9/14/202593.02 USD
9/11/202592.49 USD
9/10/202592.34 USD
9/9/202591.51 USD
9/8/202592.99 USD
9/7/202593.06 USD
9/4/202591.48 USD
9/3/202597.70 USD
9/2/202595.54 USD
9/1/202588.85 USD
8/28/202589.33 USD
8/27/202588.29 USD
8/26/202587.98 USD
8/25/202589.33 USD
8/24/202587.42 USD
8/21/202589.82 USD
8/20/202591.06 USD
8/19/202589.04 USD
8/18/202589.93 USD
8/17/202589.53 USD
8/14/202589.89 USD
8/13/202587.43 USD
8/12/202589.27 USD
8/11/202592.98 USD
8/10/202592.46 USD
8/7/202593.05 USD
8/6/202591.84 USD
8/5/202590.95 USD
8/4/202591.01 USD
Access this data via the Eulerpool API
Get Free API Key

Healthequity Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
756.56 M USD
40.57 M USD
-44.29 M USD
Jan 1, 2023
861.75 M USD
37.65 M USD
-26.14 M USD
Jan 1, 2024
999.59 M USD
129.34 M USD
55.71 M USD
Jan 1, 2025
1.20 B USD
230.07 M USD
96.70 M USD
Jan 1, 2026
1.31 B USD
322.46 M USD
215.20 M USD
Jan 1, 2027 (e)
1.42 B USD
715.96 M USD
403.23 M USD
Jan 1, 2028 (e)
1.52 B USD
769.22 M USD
465.39 M USD
Jan 1, 2029 (e)
1.63 B USD
822.81 M USD
512.97 M USD

Healthequity Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 4:58 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
20142015201620172018201920202021202220232024202520262027e2028e2029e
0.060.090.130.180.230.290.530.730.760.861.001.201.311.421.521.63
34.7840.3244.8341.2728.6525.3385.0238.043.1413.8916.0320.029.517.777.426.97
50.0052.8755.5657.3056.7760.9854.8046.2544.9745.8852.9557.7169.5469.5469.5469.54
0.030.050.070.100.130.180.290.340.340.400.530.690.910.981.061.13
11.0016.0026.0041.0054.0077.0062.0080.0040.0037.00129.00230.00322.00715.00769.00822.00
17.7418.3920.6323.0323.5826.8311.6810.915.294.3012.9119.1824.5250.5350.5950.55
1.0010.0016.0026.0047.0073.0039.008.00-44.00-26.0055.0096.00215.00403.00465.00512.00
-90.91900.0060.0062.5080.7755.32-46.58-79.49-650.00-40.91-311.5474.55123.9687.4415.3810.11
57.5559.2660.0761.8763.9270.5277.8583.5584.5787.1288.6386.9785.0185.0185.0185.01
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Healthequity generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Healthequity retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Healthequity's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Healthequity has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Healthequity's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Healthequity stock margins

The Healthequity margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Healthequity. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Healthequity.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
45.06 %
5.36 %
-5.85 %
Jan 1, 2023
45.90 %
4.37 %
-3.03 %
Jan 1, 2024
53.01 %
12.94 %
5.57 %
Jan 1, 2025
57.73 %
19.18 %
8.06 %
Jan 1, 2026
69.52 %
24.55 %
16.38 %
Jan 1, 2027 (e)
69.52 %
50.59 %
28.49 %
Jan 1, 2028 (e)
69.52 %
50.59 %
30.61 %
Jan 1, 2029 (e)
69.52 %
50.59 %
31.54 %

Healthequity Stock Revenue, EBIT, Earnings per Share

The Healthequity earnings per share therefore indicates how much revenue Healthequity has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
8.95 USD
0.48 USD
-0.52 USD
Jan 1, 2023
9.89 USD
0.43 USD
-0.30 USD
Jan 1, 2024
11.28 USD
1.46 USD
0.63 USD
Jan 1, 2025
13.80 USD
2.65 USD
1.11 USD
Jan 1, 2026
15.45 USD
3.79 USD
2.53 USD
Jan 1, 2027 (e)
16.56 USD
8.42 USD
4.72 USD
Jan 1, 2028 (e)
17.79 USD
9.05 USD
5.45 USD
Jan 1, 2029 (e)
19.03 USD
9.68 USD
6.00 USD

Healthequity business model & stock analysis

Healthequity Inc. is a company specializing in health accounts and related services. The company was founded in Utah in 2002 by Stephen Neeleman and David Hall and has since become one of the leading healthcare companies in the United States. The goal of Healthequity is to help consumers maintain control over their healthcare finances and lower their healthcare expenses. To achieve this, the company offers a variety of services that allow customers to manage their healthcare finances effectively and cost-efficiently. Healthequity's business model is based on providing health accounts that allow customers to manage and maximize their healthcare budget. The accounts are linked to various health savings (HRA, HSA, FSA) that enable customers to save money for medical expenses tax-free. The company also offers a wide range of services focused on healthcare prevention, savings, and education. For example, Healthequity offers courses and training to help customers understand their healthcare finances and reduce their healthcare costs. Healthequity has also specialized in healthcare analytics. The company offers data analysis tools that allow customers to track their healthcare costs and receipts to achieve savings. In addition, Healthequity also provides unique insights into employee health and utilization behavior, providing insights into a company's health risks and enabling more tailored offerings. The company offers various products to serve its customers. One of Healthequity's key products is the health accounts themselves, which are offered in collaboration with employers or insurers. The company has also developed special offerings for small businesses, allowing them to maintain employee participation in health accounts. Other services include unique discount programs to help customers reduce their healthcare costs. Healthequity has extensive experience working with a variety of customers and is constantly developing its wide range of offerings and services. Customers who work with the company also receive outstanding customer service and support to ensure they make the most of their healthcare finances. Overall, Healthequity is a fascinating company that enables people to better manage their healthcare costs and align them with their financial goals. Healthequity's commitment to customer service, innovation, and excellent services has made it one of the leading providers of health accounts and related services. Answer: Healthequity Inc. is a company specializing in health accounts and related services, founded in Utah in 2002. Its goal is to help consumers control their healthcare finances and lower expenses through a variety of services. The company's business model revolves around health accounts that allow customers to manage and maximize their budgets. Healthequity also offers healthcare analytics and unique insights. It offers various products, including health accounts for employers or insurers, and provides excellent customer service and support. Overall, Healthequity is a leading provider of health accounts and related services.

Healthequity SWOT Analysis

Strengths

Healthequity Inc has a strong market position with a well-established brand in the healthcare industry. The company has a solid track record of financial performance, evidenced by consistent revenue growth and profitability. Its robust technology platform provides user-friendly and secure healthcare account management solutions, which have been widely adopted by both individuals and employers.

Healthequity's extensive network of partnerships with healthcare providers and insurance companies further strengthens its competitive advantage. This enables the company to offer a wide range of healthcare services and benefits to its customers, enhancing their overall experience and satisfaction.

Weaknesses

One potential weakness for Healthequity is its dependence on the US healthcare regulatory environment. Changes in healthcare policies and regulations may impact the company's operations and profitability. Additionally, since the company primarily operates in the United States, it faces limited geographical diversification, which exposes it to regional economic fluctuations and potential market saturation.

Maintaining customer trust and data security is crucial for Healthequity. Any breach or compromise in data privacy could not only harm the company's reputation but also lead to legal and financial consequences.

Opportunities

The rising healthcare costs and increasing awareness of the importance of personal healthcare management provide Healthequity with significant growth opportunities. The company can capitalize on this by expanding its product offerings and services, targeting both individual consumers and employer-sponsored plans.

Healthequity can explore partnerships and collaborations with other companies in the healthcare technology industry to leverage synergies and expand its market reach. Additionally, the growing trend of remote and virtual healthcare delivery presents an avenue for the company to develop innovative solutions and gain a competitive edge.

Threats

Competition within the healthcare technology sector poses a threat to Healthequity. Other established players and new entrants may offer similar services, potentially eroding the company's market share. The company must continuously innovate and differentiate itself to stay ahead in this rapidly evolving industry.

Economic downturns can negatively impact consumer spending on healthcare services, affecting Healthequity's revenue growth. Additionally, changes in healthcare policies and regulations, as well as political uncertainties, could introduce challenges and disrupt the company's operations.

Healthequity Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Healthequity Employees
Details
Date
Healthequity Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

Healthequity Segments

Healthequity Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

Custodial
Custodial revenue
Service
Service revenue
Interchange
Interchange revenue
Details
Date
Custodial
Custodial revenue
Service
Service revenue
Interchange
Interchange revenue
Jan 1, 2019
0.00 USD
126.18 M USD
0.00 USD
100.56 M USD
0.00 USD
60.50 M USD
Jan 1, 2020
0.00 USD
181.89 M USD
0.00 USD
262.87 M USD
0.00 USD
87.23 M USD
Jan 1, 2021
0.00 USD
190.93 M USD
0.00 USD
430.97 M USD
0.00 USD
111.67 M USD
Jan 1, 2022
0.00 USD
202.82 M USD
0.00 USD
426.91 M USD
0.00 USD
126.83 M USD
Jan 1, 2023
0.00 USD
283.11 M USD
0.00 USD
430.20 M USD
0.00 USD
148.44 M USD
Jan 1, 2024
0.00 USD
-25.60 M USD
0.00 USD
25.60 M USD
0.00 USD
157.30 M USD
Jan 1, 2025
0.00 USD
545.41 M USD
0.00 USD
478.32 M USD
0.00 USD
176.04 M USD
Jan 1, 2026
636.80 M USD
0.00 USD
485.02 M USD
0.00 USD
191.61 M USD
0.00 USD

Healthequity Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Healthequity historical P/E ratio, EBIT multiple, and P/S ratio

Healthequity annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Healthequity shares outstanding

The number of shares of Healthequity was 86.97 M in 2025. This indicates how many shares Healthequity is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
84.57 M Stocks
Jan 1, 2023
87.12 M Stocks
Jan 1, 2024
88.63 M Stocks
Jan 1, 2025
86.97 M Stocks
Jan 1, 2026
85.01 M Stocks
Jan 1, 2027 (e)
85.01 M Stocks
Jan 1, 2028 (e)
85.01 M Stocks
Jan 1, 2029 (e)
85.01 M Stocks

Current Healthequity forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.00 % (17)
Hold
10.00 % (2)
Sell
5.00 % (1)
12M Price Target
125.97
Last Price
100.61
Currency
USD
12M Return Potential
25.21 %
LTM Return
0 %

Healthequity Analyst Rating Actions

DateFirmActionRatingReliability
7/24/2026
BTIG
BTIG
MaintainedBuy–
6/3/2026
RBC Capital
RBC Capital
MaintainedOutperform52
6/1/2026
Citizens
Citizens
MaintainedMarket Outperform–
5/29/2026
RBC Capital
RBC Capital
MaintainedOutperform52
5/22/2026
Barrington Research
Barrington Research
MaintainedOutperform–
4/9/2026
BMO Capital
BMO Capital
UpgradeMarket PerformOutperform–
3/19/2026
Deutsche Bank
Deutsche Bank
MaintainedBuy–
3/18/2026
RBC Capital
RBC Capital
MaintainedOutperform52
3/18/2026
JP Morgan
JP Morgan
MaintainedOverweight80
3/18/2026
Barrington Research
Barrington Research
MaintainedOutperform–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Healthequity Earnings Calls

2025

Healthequity Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/28/20261.13USD-355.38 MUSD-2027 Q1
3/17/20260.91USD-336.38 MUSD-2026 Q4
12/3/20250.94USD-324.24 MUSD-2026 Q3
12/9/20240.73USD-293.54 MUSD-2025 Q3
6/3/20240.68USD-280.98 MUSD-2025 Q1
3/19/20240.50USD-259.91 MUSD-2024 Q4
12/4/20230.45USD-241.50 MUSD-2024 Q3
6/5/20230.40USD-238.13 MUSD-2024 Q1
3/20/20230.32USD-224.27 MUSD-2023 Q4
12/6/20220.35USD-209.87 MUSD-2023 Q3

EESG©

Eulerpool ESG Scorecard© for the Healthequity stock

53/100
16
Environment
99
Social
45
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees69
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Healthequity shareholder structure

% Name
12.32724%
BLACKROCK, INC.
BLACKROCK, INC.
8.43040%
WASATCH ADVISORS LP
WASATCH ADVISORS LP
4.87312%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.47543%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
3.62816%
STATE STREET CORP
STATE STREET CORP
2.90954%
MORGAN STANLEY
MORGAN STANLEY
...

Healthequity Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
28.20%
Frank Medici
Frank Medici
SEC ↗
28.10%
Berkley Capital, LLC
Berkley Capital, LLC
SEC ↗
28.10%
Berkley Capital Investors, L.P.
Berkley Capital Investors, L.P.
SEC ↗
10.80%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
9.50%
Wasatch Advisors LP
Wasatch Advisors LP
SEC ↗
8.80%
Wasatch Advisors, Inc. 87-0319391
Wasatch Advisors, Inc. 87-0319391
SEC ↗
7.40%
10.
10.
SEC ↗
5.64%
Wells Fargo & Company
Wells Fargo & Company
SEC ↗
5.30%
Vanguard Capital Management
Vanguard Capital Management
SEC ↗
5.04%
Jackson Square Partners, LLC
Jackson Square Partners, LLC
SEC ↗

Healthequity Executives and Management Board

15 members · avg. age 59 · 20 % women

SC

Mr. Scott Cutler (55)

President, Chief Executive Officer, Director · since 2025

8.28 M USD

Management

MF

Mr. Michael Fiore (50)

Executive Vice President, Chief Commercial Officer

7.40 M USD
JL

Mr. James Lucania (46)

Executive Vice President, Chief Financial Officer

5.58 M USD
ER

Mr. Elimelech Rosner (68)

Executive Vice President, Chief Technology Officer

4.95 M USD
DL

Mr. Delano Ladd (44)

Executive Vice President, General Counsel

3.35 M USD
MR

Mr. Mukund Ramachandran

Chief Marketing Officer

–
RP

Mr. Richard Putnam

Investor Relations Contact · since 2016

–

Board of Directors

SN

Dr. Stephen Neeleman (57)

Founder, Vice Chairman of the Board · since 2002

2.89 M USD
RS

Mr. Robert Selander (74)

Independent Non-Executive Chairman of the Board

385,000.00 USD
AD

Mr. Adrian Dillon (71)

Independent Director

320,000.00 USD
ED

Ms. Evelyn Dilsaver (70)

Independent Director

312,014.00 USD
SP

Mr. Stuart Parker (63)

Independent Director

307,986.00 USD
DM

Ms. Debra McCowan (53)

Independent Director

295,000.00 USD

Frequently asked questions about Healthequity

Healthequity Inc operates as a leading provider of health savings accounts (HSAs) and other consumer-driven health financial services. The company's business model revolves around offering solutions that empower individuals to make informed healthcare decisions and take control of their financial well-being. Healthequity provides a comprehensive platform where individuals can save, spend, and invest healthcare dollars wisely. Through its technology-enabled services, Healthequity enables employers, benefits administrators, and health plans to reduce healthcare costs while offering employees a seamless and personalized experience. The company's commitment to innovation and customer-centricity drives its success in the healthcare financial industry.

Healthequity Inc is primarily active in the healthcare and financial services industries.

The main competitors of Healthequity Inc in the market include HSA Bank, WageWorks, and Optum Bank.

Healthequity Inc is a renowned company in the healthcare industry. Established in 2002, it is based in Draper, Utah. Specializing in health savings accounts (HSAs) and other related services, Healthequity empowers individuals to save for medical expenses. The company offers a comprehensive platform for managing HSAs, ensuring convenience and cost-effectiveness for both employers and employees. This includes online tools, mobile apps, and customer support services. With its commitment to innovation and customer satisfaction, Healthequity has gained significant recognition and its stock has performed impressively in the financial market. Invest in Healthequity Inc for a reliable healthcare investment opportunity.

Healthequity Inc has achieved significant milestones since its inception. As a leading provider of health savings accounts (HSAs), the company has consistently delivered strong financial performance and demonstrated rapid growth. Healthequity Inc has successfully established itself as a trusted partner for consumers and employers seeking to manage healthcare costs efficiently. The company's innovative technology platforms and dedicated customer service have further contributed to its success. Moreover, Healthequity Inc's strategic acquisitions and partnerships have expanded its market reach and enhanced its product offerings. These milestones highlight the company's commitment to empowering individuals to make informed healthcare decisions and secure their financial future.

Healthequity Inc is primarily present in the United States.

Healthequity Inc represents values of empowerment, accountability, and innovation. The company aims to empower individuals to take control of their own healthcare spending and savings by providing them with robust tools and resources. Healthequity Inc promotes accountability by encouraging responsible financial decisions and regularly reviewing progress towards healthcare goals. With a focus on innovation, the company continually seeks new ways to simplify healthcare financial management and enhance the overall user experience. The corporate philosophy of Healthequity Inc revolves around the belief that informed individuals can make better healthcare decisions, ultimately leading to improved health and financial outcomes.

Analysts currently set an average price target of 121.51 USD for the Healthequity stock (median: 125.97 USD), implying +20.8 % versus the latest price. The consensus is based on 20 analyst ratings.

Healthequity Analyst Price Targets 2026

20 analysts currently rate the Healthequity stock: 17 recommend buying, 2 holding and 1 selling.

Healthequity Analyst Price Targets 2026

Converted at the current exchange rate, the Healthequity share trades at 87.40 EUR (100.61 USD).

The Healthequity share (HQY) is listed on 3 stock exchanges, including: NASDAQ (HQY), Frankfurt (2HE.F), Düsseldorf (2HE.DU).

Healthequity Inc is an American company that was founded in 2002 and is based in Draper, Utah. It is one of the leading companies in the field of health accounts and health management. The business model of Healthequity focuses on providing health accounts and administration services to employers, health plans, and individuals. The company offers various products and services, including Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), Health Reimbursement Accounts (HRAs), High Deductible Health Plans (HDHPs), and other related products. Healthequity also provides its customers with a comprehensive platform for managing health accounts, which includes both mobile apps and web-based solutions. The platform allows users to manage their accounts, pay bills, access medical records, and connect with various healthcare providers. The company has also established a special division for employers who want to offer comprehensive health management for their employees. The services include the collection and management of medical data and the provision of specific health programs for employees, such as weight loss, smoking cessation, or exercise. Another area in which Healthequity is active is offering health and financial education for specific target groups such as students or retirees. The educational opportunities range from seminars to testimonials from other users. One of Healthequity's key services is maximizing the use of health accounts such as HSAs. The company focuses on helping its customers learn more about their health accounts and ensuring they can take full advantage of the benefits that such an account provides. This can result in savings of up to 60% on health insurance premiums, and reimbursement can be obtained within 24 hours after a medical bill. Healthequity relies on technology and uses it to provide its customers with the best possible experience. This includes a mobile app and web-based solutions that offer users easy access to various features, such as creating accounts, submitting expenses, or checking account balances. Overall, Healthequity offers a comprehensive range of health services and health account administration services. These are utilized by employers, health plans, and individuals to reduce costs and have better control over their health expenses.

The revenue of Healthequity is 1.31 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Healthequity is 215.20 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Healthequity is currently 39.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Healthequity stock.

The price-to-sales ratio (P/S) of Healthequity is currently 6.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Healthequity stock.

The Eulerpool Quality Score for Healthequity is 6/10.

The ISIN of Healthequity is US42226A1079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Healthequity is A119D1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Healthequity is HQY. The ticker symbol is used to trade Healthequity shares on the stock exchange.

Healthequity paid dividends every year for the past 0 years.

Healthequity is assigned to the 'Health' sector.

The dividends of Healthequity are distributed in USD.

All fundamentals and in-depth analysis of Healthequity

Our stock analysis for Healthequity stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healthequity. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Healthequity Stock
Healthequity Revenue→
Healthequity Stock
Healthequity Net Income→
Healthequity Stock
Healthequity P/E→
Healthequity Stock
Healthequity P/S→
Healthequity Stock
Healthequity EBIT→
Healthequity Stock
Healthequity Dividend→
Healthequity Stock
Healthequity Directors Dealings→
Healthequity Stock
Healthequity Stocks→
Healthequity Stock
Healthequity Market capitalization→
Healthequity Stock
Healthequity Debt→
Healthequity Stock
Healthequity Liabilities→
Healthequity Stock
Healthequity Equity→
Healthequity Stock
Healthequity AAQS→
Healthequity Stock
Healthequity Employees→
Healthequity Stock
Healthequity ROE→
Healthequity Stock
Healthequity ROA→
Healthequity Stock
Healthequity ROCE→
Healthequity Stock
Healthequity News→
Healthequity Stock
Healthequity Analyst Price Targets→

Health Stocks

HealthlynkedHealthconnHealthStreamHealthcare TriangleHealwell AlHealthcare Global EnterprisesHeart TronicsHealth&Life CoHeartbeamHealth DiscoveryHeartflowHealth CatalystAll Stocks A–Z →